Frailty clinical trials

Explore recruiting frailty clinical trials.

Recruiting frailty studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Frailty trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Using lymph nOde fine needle aspiration to assess the effeCt of pnEumococcal vAcciNe platform, Age and HIV infection on Germinal cEntre formation (OCEAN-AGE)

Netherlands

Phase III and phase IV (Integrated) EU CTIS Study details

A geroscience approach to post-acute COVID-19 syndrome (PACS) by Diet and Exercise plus rapamycin or metformin to treat Frailty and restore immune functions: a randomized, single center clinical trial.

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Alpha 2 adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): randomised controlled trial

Norway

Phase III and phase IV (Integrated) EU CTIS Study details

StAtins in Frail oldEr patients with ischemic Stroke or Transient ischemic attack – The Randomized Controlled Trial

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and safety of Dalbavancin in the treatment of infective Endocarditis caused by gram-positive cocci

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomised, double-blind, three parallel-group, placebo controlled superiority trial assessing the effect of intravenous versus oral iron supplementation on physical performance, quality of life and cognitive function in iron deficient FRAIL elderly IndiviDuals with cardiovascular disease (FRAIL-ID trial)

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Frailty trials by city

Frailty in Toronto Frailty in Vancouver Frailty in Montreal Frailty in Calgary Frailty in Edmonton Frailty in Ottawa Frailty in Winnipeg Frailty in Quebec City Frailty in Hamilton Frailty in Kitchener Frailty in London Frailty in Halifax Frailty in New York Frailty in Los Angeles Frailty in Chicago Frailty in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease